LORMA COLLEGES CON TEMPLATE

DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023  Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Macrolide antibiotic Erythromycin acts Used to prevent Minor ocular irritation;  Hypersens Assessment and
erythromycin by inhibition of certain eye hypersensitivity itivity monitoring
protein synthesis infections of reactions
BRAND:   Minor  Ensure informed
by binding to the newborn babies,
Ilotycin SPECIAL ocular consent.
23S ribosomal such as neonatal reactions
PRECAUTION:  Assess eyes for
Dosage and RNA molecule in conjunctivitis and  Redness drainage or
route: the 50S subunit of ophthalmia May result in overgrowth crusting.
Topical eye ribosomes in neonatorum.  of nonsusceptible  Monitor for side
ointment / susceptible organisms, including effects after
ophthalmic route bacterial fungi. administration.
Do not let tip of
organisms. It applicator touch eye; Administration
stops bacterial avoid contamination.
protein synthesis
by inhibiting the  Administer
transpeptidation/tr within one hour
anslocation step after delivery
of protein
synthesis and by  Clean eyes prior
inhibiting the to administration
 Apply 1 cm
assembly of the ribbon of
50S ribosomal ointment to the
subunit. lower
conjunctival sac
of each eye
o Inner to
outer
canthu
s
 Avoid
contamination of
applicator tip
 Close the eyes
for 30–60
seconds
 Wipe away any
excess ointment
around the
periorbital skin

Client education

 Purpose of
medication
 Potential side
effects
 Avoid wiping
away ointment
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Viral vaccines Induces specific  History of  diarrhea,  Obtain consent
hepatitis B humoral Active allergic reaction loss of  Give IM
pediatric vaccine antibodies against immunization to hepatitis B appetite; injection in
vaccine or to  feeling
HBsAg (anti-HBs against hepatitis B lateral side of
BRAND:  any ingredient weak or
Recombivax HB antibodies). It is virus infection. tired; middle 3rd of
in the
generally formulation;  mild vastus lateralis
Dosage and accepted that an HBsAg carriers. fussiness muscle
route: anti-HBs titre Safe use during or crying;  Monitor
 intramuscular greater than 10 pregnancy  low fever; temperature.
suspension (10 IU/L correlates (category C) or Some patients
mcg/0.5 mL; 5 and lactation is  runny
with protection develop a
mcg/0.5 mL) not established. nose.
against hepatitis temperature
B virus infection.  SPECIAL elevation of
PRECAUTION:  38.3° C (101°
F) following
 Not protective vaccination that
against hepatitis may last 1 or 2
d.
A, C, or E

 Gluteal muscle
 Document per
injection is not policy; Typically
recommended includes
documenting in
hospital chart
and providing a
card to the
parents for their
records
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: immunostimulants  BCG BCG vaccine  Immunosuppres  Wheal  Do not massage
Bacillus vaccination activa provides immunity ed individual formation area of injection
Calmette-Guerin tes the innate or protection due to  Koch  A scar will
(BCG) Vaccine malignant
immune system against phenomen formed 12
BRAND:  disease (child
and induces tuberculosis (TB). with clinical on weeks after
TheraCys® BCG
changes in the TB is a very AIDS); therapy (inflammat injection
Dosage and pattern of histone serious infectious with ory  Repeat BCG
route: modifications of disease that can immunosuppres reaction 2- vaccination if
0.05 mL via slow specific genes in cause TB sive agent or 4 days) the child does
injection into the innate immune meningitis in radiation not develop a
deltoid muscle. cells. babies. scar after first
injection
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Fat-soluble vitamin Cofactor for Prevention of None  Pain and Administration
Vitamin K gamma-glutamyl hemorrhage erythema
carboxylase, caused by vitamin at the  IM
BRAND:  injection administration in
which converts K deficiency
 Mvi Pediatric site vastus lateralis
the inactive forms  Skin rash  Provide comfort
Dosage and of coagulation or urticaria measures, pain
route: factors II, VII, IX,  Hypersens management
and X into their itivity
IM 2mcg active forms reactions
 Hyperbiliru Assessment
binemia
 Monitor for side
 effects: e.g.,
pain and
erythema at the
injection site,
skin rash or
urticaria,
hypersensitivity
reactions,
hyperbilirubinem
ia
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Anti-anxiety agents, Midazolam is This medication is Hypersensitivity to  Nausea, vo
Midazolam sedative/hypnotics mediated through used by children benzodiazepines. miting, dizz  Before
BRAND:  the inhibitory before a procedure Chronic respiratory iness, or administering,
Dormicum have oxygen
neurotransmitter or anesthesia to insufficiency drowsiness
and
Dosage and gamma- cause drowsiness, may resuscitation
route: aminobutyric acid decrease anxiety, occur.  equipment
(GABA), which is and cause available in
inject 2.5mg one of the major forgetfulness of the case of severe
for2minute(never inhibitory surgery or respiratory
as bolus) IM:0.07- neurotransmitters procedure. It should depression.
 Monitor and
0.08 in the central be used while the record patient
mg/kgRoute:IM, nervous system. child is under the response to
IV Benzodiazepines care of a health medication and
increase the professional. It is level of
activity of GABA, not for home or sedation.
thereby producing  Observe site
a sedating effect, long-term use. closely for
relaxing skeletal extravasation.
muscles, and  Monitor for
adverse
inducing sleep,
reactions.
anesthesia, and  Continuous
amnesia.  cardiorespirator
y monitoring.
 Monitor BP and
oxygen
saturation.
 Assess sedated
infant for signs
of pain
(midazolam
does not
possess
analgesic
properties).


LORMA COLLEGES CON TEMPLATE

DRUG STUDY
 RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Opioid agonist Morphine and its Hypersensitivity to  drowsines  Monitor patient's
Morphine sulfate metabolites act as Morphine is used morphine; respiratory respiratory rate
s,
agonists of the for the insufficiency or prior to
BRAND:   dizziness,
mu and kappa management of depression; administration.
Statex  tiredness,
Dosage and opioid chronic, moderate severe CNS depression;  Reassess pain
receptors.1 The to severe pain. attack of  constipatio after
route:10 to 30 mg
every 4 hours  mu-opioid bronchial asthma; heart n, administration of
receptor is failure secondary to  stomach morphine.
integral to chronic lung pain,  Monitor for
morphine's effects disease;cardiac arrhythm  nausea, respiratory
on the ventral ias;increased intracranial depression and
 vomiting,
tegmental area of or cerebrospinal hypotension
the brain.  pressure;head  sweating, frequently up to
injuries;brain tumor; and 24 hours after
acute alcoholism; deliriu  feelings of administration of
m tremens; convulsive extreme morphine.
disorders happiness  Place call light
or sadness signal close to
patient. 
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Analgesic (nonopioid) it is often It is an analgesic  Contraindicated  CNS:  Do not exceed the
Paracetamol Antipyretic categorized and antipyretic with allergy to headache recommended
alongside drug that is used to acetaminophen.  CV: chest dosage.
BRAND:  pain,dyspne  Reduce dosage
NSAIDs temporarily relieve  Use cautiously
Alvedon a,myocardial with hepatic
(nonsteroidal anti- mild-to-moderate with impaired damage impairment.
Dosage and inflammatory pain and fever.  hepatic when doses  Avoid using
route: drugs) due to its function, of 5-8g/day multiple prepara
500mg/ ability to inhibit chronic are ingested tions containing
tabFrequency:PR the alcoholism, pre daily for acetaminophen.
N not cyclooxygenase gnancy, severalweek Carefully check all
s or when OTC product
exceeding3900m (COX) pathways. lactation
does of  Give drug with food
g/day It is thought to 4g/day are if GI upset occurs.
exert central ingested for  Discontinue drug if
actions which 1yr hypersensitivity
ultimately lead to  GI: hepatic reactions occur
the alleviation of toxicity and
pain symptoms. failure, jaun
dice
 GU: acute
renal
failure,
renal
tubular
necrosis
 Hematologic:
methemoglo
binemia-
cyanosis;
hemolytic
anemia-
hematuria,
anuria;neutro
penia,leukop
enia, pancy
topenia,thr
ombocytope
nia,hypoglyc
emia
 Hypersensiti
vity: rash,
fever
 LORMA COLLEGES CON TEMPLATE
DRUG STUDY
RELATED LEARNING EXPERIENCE

STUDENT NAME: MANANSALA, Zhairralyn Gabrielle B.  ROTATION: 3rd Rotation AREA: NICU
YR LEVEL AND SEC: CLINICAL INSTRUCTOR:
  BSN 4 KOLCABA DATES: March 6,7,8 2023   Anna liza E. Wenceslao, MAN

DRUG NAME CLASSIFICATION MECHANISM OF INDICATION CONTRAINDICATION SIDE EFFECTS NURSING

ACTION RESPONSIBILITIES
GENERIC: Alkalinizing Agents Sodium Sodium  Metabolic or  Hypersens  Assess the
Sodium bicarbonate is a bicarbonate is respiratory client’s fluid
bicarbonate alkalosis itivity, balance
systemic indicated in the
 Hypocalcemia metabolic throughout the
alkalizer, which treatment of
BRAND:   Excessive or therapy. This
Bicarbisaph increases plasma metabolic acidosis  chloride loss assessment
bicarbonate, which may occur in respiratory
 It is not includes intake
Dosage and buffers excess severe renal recommended alkalosis, h and output, daily
route: hydrogen ion disease, as an antidote ypocalcem weight, edema
1 mEq/kg/dose concentration, uncontrolled diabet following and lung
ia,
intravenous (IV) and raises blood es, circulatory insu ingestion of sounds.
x1 strong mineral excessive  Symptoms of
pH, thereby fficiency due
acids chloride fluid overload
reversing the to shock or severe  Patients on should be
clinical dehydration, extrac (Cl-) loss
sodium reported such
manifestations of orporeal circulation  restricted diet from as hypertension,
acidosis. of blood, cardiac  Renal failure vomiting edema, difficulty
arrest and severe  Severe abdomi breathing or
nal pain of or GI sucti dyspnea, rales
primary lactic
unknown cause oning or crackles and
acidosis. 
especially if  Patients at frothy sputum.
associated with  Sigs of acidosis
risk of
fever should be
developing  assessed such
SPECIAL diuretic- as
PRECAUTION: disorientation,
induced
headache,
 Not first-line for hypochlore weakness,
resuscitation mic dyspnea and
 Use with hyperventilation.
caution in alkalosis
 Assess for
patients with  Hypercarbi alkalosis by
congestive c acidosis monitoring
heart failure, the client for
severe renal  Unknown
confusion,
insufficiency, abdominal irritability,
edematous or pain paresthesia,
sodium- tetany and
retaining states, altered
HTN, children breathing
with DKA, and pattern.
concurrent  Hypernatremia
corticosteroid clinical
use manifestations
 IV should be
administration assessed and
can cause fluid monitored which
and/or solute includes:
overloading edema, weight
resulting in gain,
dilution of hypertension,
serum tachycardia,
electrolyte
concentrations, fever, flushed
overhydration, skin and mental
congested irritability.
states or
pulmonary
edema.